Kuhnil Pharm. Signs Licensing Agreement with Mochida Pharmaceutical for Highly Purified EPA formulation ‘EPADEL’
Kuhnil Pharm. Co., Ltd. (CEO Han-Kuk Lee) and Mochida Pharmaceutical Co., Ltd. (President Naoyuki Mochida) announced on December 16th that the companies have entered into an agreement for ‘EPADEL,’ the original formulation of highly purif...